Literature DB >> 2949988

Inhibitory effect of centrally administered atrial natriuretic polypeptide on the brain dopaminergic system in rats.

K Nakao, G Katsuura, N Morii, H Itoh, S Shiono, T Yamada, A Sugawara, M Sakamoto, Y Saito, M Eigyo.   

Abstract

The effects of intracerebroventricular injection of atrial natriuretic polypeptide (ANP) and angiotensin II (AII) on the concentration of dopamine, noradrenaline, serotonin and their primary metabolites in the rat brain were studied using high performance liquid chromatography with electrochemical detection. ANP (2 and 5 micrograms) decreased the level of dopamine and its metabolite in the septum and hypothalamus. In contrast, AII (100 ng) increased their levels in these brain regions. The simultaneous administration of ANP (5 micrograms) with AII (100 ng) resulted in a marked reduction of the AII-induced increase of dopamine and its metabolite. No significant changes were observed in the concentrations of noradrenaline and serotonin throughout the brain. These results suggest that the central action of ANP is mediated in part via the dopaminergic system.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2949988     DOI： 10.1016/0014-2999(86)90570-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Receptor sites for atrial natriuretic factors in brain and associated structures: an overview.

Authors:  R Quirion
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

2.  Evidence for a dopaminergic mechanism for the diuretic and natriuretic action of centrally administered atrial natriuretic factor.

Authors:  A Israel; M Torres; Y Barbella
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

3.  Effects of atrial natriuretic factor on anterior pituitary hormone secretion in normal man.

Authors:  M Kentsch; R Lawrenz; P Ball; R Gerzer; G Müller-Esch
Journal:  Clin Investig       Date:  1992-07

Review 4.  Discovery of atrial natriuretic factor in the brain: its characterization and cardiovascular implication.

Authors:  T Inagami; I Tanaka; J C McKenzie; M Nakamaru; R Takayanagi; T Imada; R Pochet; A Resibois; M Naruse; K Naruse
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

5.  Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice.

Authors:  Nobuko Yamada-Goto; Goro Katsuura; Ken Ebihara; Megumi Inuzuka; Yukari Ochi; Yui Yamashita; Toru Kusakabe; Akihiro Yasoda; Noriko Satoh-Asahara; Hiroyuki Ariyasu; Kiminori Hosoda; Kazuwa Nakao
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

6.  Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice.

Authors:  Namiko Kawamura; Goro Katsuura; Nobuko Yamada-Goto; Ela Novianti; Akio Inui; Akihiro Asakawa
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02

7.  Genes associated with hot defensive bee ball in the Japanese honeybee, Apis cerana japonica.

Authors:  Takahiro Kamioka; Hiromu C Suzuki; Atsushi Ugajin; Yuta Yamaguchi; Masakazu Nishimura; Tetsuhiko Sasaki; Masato Ono; Masakado Kawata
Journal:  BMC Ecol Evol       Date:  2022-03-16

8.  Brain fractalkine-CX3CR1 signalling is anti-obesity system as anorexigenic and anti-inflammatory actions in diet-induced obese mice.

Authors:  Namiko Kawamura; Goro Katsuura; Nobuko Yamada-Goto; Riho Nakama; Yuki Kambe; Atsuro Miyata; Tomoyuki Furuyashiki; Shuh Narumiya; Yoshihiro Ogawa; Akio Inui
Journal:  Sci Rep       Date:  2022-07-23       Impact factor: 4.996
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.